Quick answer
How do GHK-Cu and BPC-157 compare in skin repair research? They come from separate literatures. GHK-Cu evidence centers on fibroblast collagen synthesis and a topical rat ischemic-flap wound model; BPC-157 evidence centers on a rat alkali-burn skin model, endothelial angiogenesis assays and tendon fibroblasts. The cited sources do not test them together, and most BPC-157 work comes from small rodent models.
Searches for "skin repair BPC-157 GHK-Cu preclinical models" are usually looking for a single verdict. The published record is better read as two maps drawn by different people. This article overlays them, shows the readouts each used and says where a comparison cannot be made. For laboratory research use only; not for human consumption.
Why put these two peptides side by side
GHK-Cu and BPC-157 are often mentioned together in skin and tissue repair discussions, yet they come from different chemistry and different literatures. GHK-Cu is a copper-binding tripeptide, glycyl-L-histidyl-L-lysine, first isolated from human plasma; BPC-157 is a pentadecapeptide described as a partial sequence of a protein isolated from human gastric juice [1][2]. This article lines up the preclinical models used for each, so a researcher can see which questions each peptide has actually been tested on, which readouts were used and where the evidence is thinnest. It does not recommend either compound for anything, and it does not claim the two have been tested together: none of the sources cited here did that.
Product facts come from the live pages. The GHK-Cu product page describes a copper-bound Gly-His-Lys tripeptide as lyophilized powder in 50 mg and 100 mg sizes with ≥98% HPLC purity, and lists collagen-synthesis research models, dermal-remodeling studies and gene-expression research as its research applications. The BPC-157 product page is the corresponding page for the pentadecapeptide. Background is in the GHK-Cu overview and the BPC-157 overview.
The model map
The table lists the primary studies behind each peptide's skin and wound-repair literature, with system, route as reported and finding. Each row is stated for the exact molecule that was tested.
| Peptide | System | Route or exposure as reported | Reported finding | Source |
|---|---|---|---|---|
| GHK-Cu | Cultured fibroblasts | Added to culture medium | Stimulated collagen synthesis beginning between 10-12 and 10-11 M, maximal at 10-9 M, independent of change in cell number | Maquart et al., 1988 [1] |
| GHK-Cu (tripeptide-copper complex in a gel) | Rat ischemic bipedicle skin flap, 6 mm full-thickness wounds, 24 rats | Topical, daily for 13 days; vehicle and untreated controls | Wound area decreased by 64.5% (complex), 45.6% (vehicle) and 28.2% (control) by day 13; lower TNF-alpha and MMP levels in complex-exposed wounds on days 6, 10 and 13 | Canapp et al., 2003 [3] |
| BPC-157 | Rat alkali-burn skin wound | Topical | Accelerated wound closure; better granulation tissue, re-epithelialization, dermal remodeling and collagen deposition at day 18; higher VEGF expression | Huang et al., 2015 [4] |
| BPC-157 | HUVEC cultures | Added to culture medium | Enhanced proliferation and migration, VEGF-a expression and tube formation; ERK1/2 phosphorylation and downstream c-Fos, c-Jun and Egr-1 regulation | Huang et al., 2015 [4] |
| BPC-157 | Rat Achilles tendon explants and tendon fibroblasts | Added to culture medium | Accelerated outgrowth from explants; no direct effect on fibroblast proliferation by MTT; improved survival under H2O2 stress; dose-dependent migration, with FAK and paxillin activation | Chang et al., 2011 [5] |
The table already shows the main structural difference. The GHK-Cu skin literature leans on fibroblast collagen biology and on a topical wound model in rats, while the BPC-157 skin evidence is a rat burn model plus endothelial cell work on angiogenesis, with tendon as its other main system. Two sets of papers answering different questions are not evidence that the peptides behave alike.
Reading the GHK-Cu evidence
Maquart and colleagues reported that GHK-Cu stimulated collagen synthesis by fibroblasts, with the effect appearing between 10-12 and 10-11 M, maximal at 10-9 M and independent of cell number, and noted that a GHK triplet occurs in the alpha-2(I) chain of type I collagen, which suggests the tripeptide might be released by proteases at a wound [1]. That is a cell-culture result with a molar concentration range, and it is the foundational datum behind the product page's collagen-synthesis research application.
The rat flap study adds an in vivo model with a deliberate design: a bipedicle skin flap makes the wound ischemic, so healing is impaired, and the study included a vehicle group (hydroxypropyl-methylcellulose) and an untreated group [3]. The vehicle group also closed more than the untreated group (45.6% versus 28.2% by day 13), so part of the apparent effect of any topical preparation comes from the vehicle itself; the complex still exceeded the vehicle on some days (days 3 and 9) [3]. A reader should look for the vehicle arm in every topical study, because without it vehicle effects are attributed to the active molecule. The review literature by the group that discovered GHK adds a broader picture of reported actions, including collagen and glycosaminoglycan effects and gene-expression data [6][7]; reviews restate primary work and, in this case, come from the laboratory that developed the compound, which is worth keeping in mind when weighing them.
Reading the BPC-157 evidence
The alkali-burn study is the most skin-specific BPC-157 paper in this set. Topical exposure accelerated closure of rat alkali burns, and histology with hematoxylin-eosin and Masson staining showed better granulation tissue, re-epithelialization, dermal remodeling and collagen deposition than in the model control on day 18, with higher VEGF expression in the wound tissue [4]. The in vitro arm used human umbilical vein endothelial cells and linked the peptide to ERK1/2 phosphorylation and to c-Fos, c-Jun and Egr-1, which are key molecules in growth, migration and angiogenesis [4]. The tendon paper is not a skin paper, but it contributes the finding that BPC-157 did not directly alter fibroblast proliferation by MTT while improving survival under oxidative stress and driving migration via FAK-paxillin [5]. A 2019 review concluded that the studies so far were consistently positive, but also stated that most were performed in small rodent models, that efficacy in humans was yet to be confirmed and that only a handful of research groups had done in-depth studies [2]. That last point deserves emphasis: a body of work from few laboratories is less independently replicated than the volume of papers suggests.
Same word, different readouts: what "repair" means in each assay
The word "healing" hides several different measurements, and comparing the two peptides requires keeping them apart.
| Readout | What it measures | Used for GHK-Cu | Used for BPC-157 |
|---|---|---|---|
| Collagen synthesis | Matrix production by fibroblasts | Yes, culture [1] | Collagen deposition by histology [4] |
| Wound area closure | Gross closure over time | Yes, rat flap [3] | Yes, rat burn [4] |
| Inflammatory and protease markers | TNF-alpha, MMP-2 and MMP-9 | Yes [3] | Not in these sources |
| Angiogenesis | Endothelial proliferation, migration, tube formation, VEGF | Not in these sources | Yes [4] |
| Cell migration | Transwell and scratch assays | Not in these sources | Yes, endothelial and tendon cells [4][5] |
| Cell survival under stress | Viability under H2O2 | Not in these sources | Yes, tendon fibroblasts [5] |
The blank cells are as informative as the filled ones. They are readouts that were not reported in the cited papers; other papers may have measured them, and this article does not claim otherwise, only that the matching comparison cannot be made from these sources.
Design points for a skin-repair experiment
- Include the vehicle arm. The rat flap study shows vehicle alone moving wound area [3].
- Choose the cell type for the question. Fibroblasts for matrix output, endothelial cells for vessel formation, keratinocytes for re-epithelialization; each peptide has been tested in only some of these.
- Pick readouts at matching time points. Collagen deposition was read at day 18 in the burn model [4] and wound area daily to day 13 in the flap model [3]; a protocol needs time points chosen in advance.
- Mind the copper. GHK-Cu carries copper, so metal-sensitive assays and combination preparations need controls for copper alone; the library article on copper and other peptides in a blend explains why.
- Verify the material. GHK-Cu purity testing, how to read a COA and the COA library cover documentation.
Arithmetic for stock solutions comes from the calculator and peptide reconstitution volume calculations; the published molar range in the culture study can be converted to mass per volume with the molar mass of the complex, a formula, not a table. For further reading on related published work, see GHK-Cu versus other copper peptides and BPC-157 versus TB-500, and browse the shop.
All material discussed here is supplied for laboratory research use only; not for human consumption, and nothing in this article is a recommendation for any use outside a research setting.
Frequently asked questions
Have GHK-Cu and BPC-157 been tested together in skin models?
Not in the sources cited here. Each peptide has its own set of models, and comparing them requires care.
What did the original GHK-Cu collagen study find?
GHK-Cu stimulated collagen synthesis in cultured fibroblasts from about 10-12 to 10-11 M, with a maximum at 10-9 M, independent of cell number.
What rat model was used for the topical tripeptide-copper study?
Full-thickness 6 mm wounds in an ischemic bipedicle skin flap on the backs of 24 rats, with a vehicle group and an untreated group.
Did the vehicle alone have an effect in that study?
Yes. Wound area decreased by 45.6% in the vehicle group and 28.2% in the untreated group by day 13, versus 64.5% for the complex.
What skin evidence exists for BPC-157?
A rat alkali-burn study reported faster closure, better granulation tissue, dermal remodeling and collagen deposition at day 18, plus endothelial cell results on angiogenesis.
Did BPC-157 increase fibroblast proliferation?
In rat tendon fibroblasts it did not directly affect proliferation by MTT, but it improved survival under oxidative stress and promoted migration.
Why does a review from few laboratories matter?
A 2019 review noted that only a handful of groups had done in-depth BPC-157 studies, so independent replication is limited.
What should a protocol always include?
A vehicle arm, time points chosen in advance, readouts matched to the question and documented identity and purity of the material.
What forms do the product pages list?
Both are lyophilized powders; the GHK-Cu page lists 50 mg and 100 mg sizes with ≥98% HPLC purity.
Related reading: GHK-Cu Beginner Guide: Color, Vials and Controls.
References
- Maquart FX, Pickart L, Laurent M, Gillery P, Monboisse JC, Borel JP. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988;238(2):343-6. doi:10.1016/0014-5793(88)80509-x
- Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. 2019;377(2):153-159. doi:10.1007/s00441-019-03016-8
- Canapp SO Jr, Farese JP, Schultz GS, Gowda S, Ishak AM, Swaim SF, et al. The effect of topical tripeptide-copper complex on healing of ischemic open wounds. Vet Surg. 2003;32(6):515-23. doi:10.1111/j.1532-950x.2003.00515.x
- Huang T, Zhang K, Sun L, Xue X, Zhang C, Shu Z, et al. Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro. Drug Des Devel Ther. 2015;9():2485-99. doi:10.2147/DDDT.S82030
- Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol (1985). 2011;110(3):774-80. doi:10.1152/japplphysiol.00945.2010
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015():648108. doi:10.1155/2015/648108
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):. doi:10.3390/ijms19071987
